| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.76 | 0.65 | 0.28 | 0.62 | 1.10 |
| Long Term Debt-Equity Ratio | 0.42 | 0.41 | 0.20 | 0.21 | 0.18 |
| Current Ratio | 1.60 | 1.65 | 1.64 | 1.32 | 1.19 |
| Fixed Assets | 3.58 | 3.38 | 4.75 | 3.70 | 4.98 |
| Inventory | 4.20 | 4.62 | 7.42 | 4.50 | 3.50 |
| Debtors | 3.01 | 3.87 | 5.65 | 4.21 | 3.61 |
| Interest Cover Ratio | 8.53 | 13.98 | 24.62 | 5.23 | 3.17 |
| PBIDTM (%) | 18.35 | 19.87 | 19.40 | 17.97 | 15.28 |
| PBITM (%) | 16.24 | 16.64 | 16.97 | 14.63 | 11.62 |
| PBDTM (%) | 16.45 | 18.68 | 18.71 | 15.18 | 11.61 |
| CPM (%) | 12.79 | 14.77 | 14.73 | 12.41 | 9.65 |
| APATM (%) | 10.68 | 11.54 | 12.30 | 9.07 | 5.99 |
| ROCE (%) | 16.52 | 21.87 | 43.99 | 27.51 | 19.66 |
| RONW (%) | 19.57 | 25.84 | 43.31 | 29.22 | 22.17 |